Inactive Instrument

Calendar Novogen Limited Australian S.E.

Equities

AU000000NRT0

Chart calendar Novogen Limited

7d46c54dd8cf.S9JkM5oKxNstvHhY85d_lnuv-oBW3Ff-plQWd1PmZGA.DasuRNkzsJVD_x4thtkb_xbVgs4Y5A6EzT9VPCKpOyYYlQB4_l2IvFjpOQ~898eac4075624a6e721e4036a8a709ba

Upcoming events on Novogen Limited

Today 02:30 am Pediatric Neuro Oncology International Symposium
02/07/2024 05:45 pm Pediatric Neuro Oncology International Symposium
29/08/2024 Q4 2024 Earnings Release (Projected)
19/02/2025 Q2 2025 Earnings Release (Projected)
28/08/2025 Q4 2025 Earnings Release (Projected)

Past events on Novogen Limited

10/04/2024 03:20 am American Association for Cancer Research Meeting - Abstract No 6565
08/04/2024 09:30 pm American Association for Cancer Research Meeting - Abstract No CT088
08/04/2024 02:00 am American Association for Cancer Research Meeting - Abstract No 1059
30/11/2023 04:30 am Annual General Meeting
19/11/2023 Society for Neuro Oncology Meeting - PNOC022 A Combination Therapy
17/11/2023 05:30 pm Society for Neuro Oncology Meeting
17/11/2023 Society for Neuro Oncology Meeting - Combining ONC201 and Paxalisib
31/10/2023 04:22 am September 2023 Sales and Revenue Release - Activities Report
21/10/2023 European Society for Medical Oncology Congress
12/09/2023 09:30 am H.C. Wainwright Global Investment Conference
31/08/2023 12:51 pm Q4 2023 Earnings Release

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million AUD
Released
Forecast
Spread
1,47
3,07
-52.33%
1,00
2,75
-63.82%
15,2
18,7
-18.81%
0,03
0,27
-90.14%
0,02
0,01
100.96%
EBITDA
Million AUD
Released
Forecast
Spread
-7,61
-10,5
27.33%
-11,0
-8,70
-26.88%
0,00
0,00
-
-23,1
-24,1
4.33%
0,00
0,00
-
EBIT
Million AUD
Released
Forecast
Spread
-10,7
-11,9
10.6%
-12,8
-9,95
-28.96%
-6,38
-7,40
13.81%
-25,0
-25,6
2.23%
-24,1
-25,9
6.68%
Earnings before Tax (EBT)
Million AUD
Released
Forecast
Spread
-10,6
-11,9
10.99%
-12,8
-9,95
-28.3%
-8,91
-7,20
-23.7%
-25,0
-27,0
7.46%
-20,7
-27,2
23.76%
Net income
Million AUD
Released
Forecast
Spread
-10,3
-11,9
13.51%
-12,5
-9,90
-25.93%
-8,42
-7,20
-16.97%
-24,6
-27,0
8.82%
-20,5
-25,8
20.68%
EPS
AUD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-1,86
-1,15
-62.25%
0,00
0,00
-
Announcement Date28/08/1926/08/2025/08/2128/08/2231/08/23

Quarterly results

Fiscal PeriodJune 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales
Million AUD
Released
Forecast
Spread
0,00


0,37
3,40
-89.14%
0,03
0,61
-94.75%
15,2
18,7
-18.82%
0,03
0,00
-
0,00
0,34
-99.97%
0,00
0,00
-87.27%
0,02
0,01
99.74%
EBIT
Million AUD
Released
Forecast
Spread



-6,77
-4,00
-69.22%
-6,51
-7,70
15.38%
0,06
-1,00
106%
-13,3
-9,30
-42.63%
-11,7
-11,8
0.86%



-10,5
-12,2
13.92%
Earnings before Tax (EBT)
Million AUD
Released
Forecast
Spread















-11,7
-13,6
14.14%






Net income
Million AUD
Released
Forecast
Spread
-5,88














-11,6
-13,6
14.52%
-13,6


-6,88
-10,8
36.41%
EPS
AUD
Released
Forecast
Spread















-0,87
-0,10
-774.6%






Announcement Date19/02/2026/08/2024/02/2125/08/2123/02/2228/08/2228/02/2331/08/23